Epigenetic Biomarkers in Gynecological Cancers Explored
Dr. Lewis Francis, of Swansea University, discusses ChIP methods used in his research on the role of epigenetics in ovarian and endometrial cancers
Dr. Lewis Francis, of Swansea University, discusses ChIP methods used in his research on the role of epigenetics in ovarian and endometrial cancers
Dr. Nobuo Horikoshi explains his research on the epigenetics of DNA repair and how a timely switch of techniques yielded a higher chromatin recovery
Cancer epigeneticist, Dr. Sammy Ferri-Borgogno, of the MD Anderson Cancer Center, Texas, tells SelectScience® how live cell imaging reveals more information about pancreatic cancer cells while saving time and money
Chromatrap® announces that seven further popular antibodies have been validated for use in chromatin immunoprecipitation (ChIP) assays by their UK-based research team
Fluorescent light switch engineered into bacterial metabolite sensor to leap-frog limitations of conventional reagents
Collaboration to look into link between epigenetics and respiratory disease
Chromatrap announces that its high quality ChIP-validated antibodies can now be supplied with optimized matching primer sets
Liquid biopsy test delivers high negative predictive value of 99.2% for bladder cancer
Advances in biomarker research using Droplet Digital™ PCR
New Application Notes, Product and Webinar
Discover seven applications to improve your cancer research methods